These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 15496256)

  • 41. Why was Toronto included in the World Health Organization's SARS-related travel advisory?
    Rodier GR
    CMAJ; 2003 May; 168(11):1434-5. PubMed ID: 12771075
    [No Abstract]   [Full Text] [Related]  

  • 42. From the Centers for Disease Control and Prevention. Severe acute respiratory syndrome--Taiwan, 2003.
    JAMA; 2003 Jun; 289(22):2930-2. PubMed ID: 12799395
    [No Abstract]   [Full Text] [Related]  

  • 43. In Beijing during the SARS outbreak.
    Borwein S
    Can Fam Physician; 2004 Jun; 50():861-3. PubMed ID: 15233366
    [No Abstract]   [Full Text] [Related]  

  • 44. SARS. What have we learned?
    Marthaler M; Keresztes P; Tazbir J
    RN; 2003 Aug; 66(8):58-64. PubMed ID: 13677684
    [No Abstract]   [Full Text] [Related]  

  • 45. Patient satisfaction with doctor-patient interaction in a radiotherapy centre during the severe acute respiratory syndrome outbreak.
    Tang JI; Shakespeare TP; Zhang XJ; Lu JJ; Liang S; Wynne CJ; Mukherjee RK; Back MF
    Australas Radiol; 2005 Aug; 49(4):304-11. PubMed ID: 16026437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What you need to know about SARS now.
    Dreher HM; Dean JL; Moriarty DM; Kaiser R; Willard R; O'Donnell S; Virella J; O'Brien C; Marcolongo C; Regn K; Constans C; Sowden R; Phung L
    Nursing; 2004 Jan; 34(1):58-63; quiz, 63-4. PubMed ID: 14722438
    [No Abstract]   [Full Text] [Related]  

  • 47. A new disease emerges: severe acute respiratory syndrome (SARS).
    Dolan SA
    J Spec Pediatr Nurs; 2003; 8(2):75-6. PubMed ID: 12875176
    [No Abstract]   [Full Text] [Related]  

  • 48. Planning for epidemics--the lessons of SARS.
    Weinstein RA
    N Engl J Med; 2004 Jun; 350(23):2332-4. PubMed ID: 15175434
    [No Abstract]   [Full Text] [Related]  

  • 49. SARS: a closer look at this emerging infectious agent.
    Benjamin GC
    Physician Exec; 2003; 29(4):72-4. PubMed ID: 14650077
    [No Abstract]   [Full Text] [Related]  

  • 50. A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic.
    Leung GM; Quah S; Ho LM; Ho SY; Hedley AJ; Lee HP; Lam TH
    Infect Control Hosp Epidemiol; 2004 Dec; 25(12):1033-41. PubMed ID: 15636289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WHO issues global alert on respiratory syndrome.
    Parry J
    BMJ; 2003 Mar; 326(7390):615. PubMed ID: 12649215
    [No Abstract]   [Full Text] [Related]  

  • 52. [Severe acute respiratory syndrome].
    Kuś J
    Pneumonol Alergol Pol; 2003; 71(3-4):117-20. PubMed ID: 14587416
    [No Abstract]   [Full Text] [Related]  

  • 53. SARS: what have we learned?
    Pearson H; Clarke T; Abbott A; Knight J; Cyranoski D
    Nature; 2003 Jul; 424(6945):121-6. PubMed ID: 12853923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS--emerging illness causing widespread concern.
    Mayo Clin Health Lett; 2003 Jun; 21(6):4. PubMed ID: 12793364
    [No Abstract]   [Full Text] [Related]  

  • 55. Estimating SARS incubation period.
    Wong TW; Tam W
    Emerg Infect Dis; 2004 Aug; 10(8):1503-4; author reply 1504. PubMed ID: 15503397
    [No Abstract]   [Full Text] [Related]  

  • 56. Update: severe acute respiratory syndrome--United States, June 4, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jun; 52(22):525-6. PubMed ID: 12803200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lessons from SARS.
    CMAJ; 2003 May; 168(11):1381, 1383. PubMed ID: 12771050
    [No Abstract]   [Full Text] [Related]  

  • 58. Sources of information and health beliefs related to SARS and avian influenza among Chinese communities in the United Kingdom and The Netherlands, compared to the general population in these countries.
    Voeten HA; de Zwart O; Veldhuijzen IK; Yuen C; Jiang X; Elam G; Abraham T; Brug J
    Int J Behav Med; 2009; 16(1):49-57. PubMed ID: 19184453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a SARS vaccine: an industrial perspective on the global race against a global disease.
    Viret JF; Glück R; Moser C
    Expert Rev Vaccines; 2003 Aug; 2(4):465-7. PubMed ID: 14711331
    [No Abstract]   [Full Text] [Related]  

  • 60. My experience with SARS.
    Cheung CM
    CMAJ; 2003 Dec; 169(12):1284-5. PubMed ID: 14662665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.